NM_024675.4(PALB2):c.2368C>T (p.Gln790Ter) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- Jun 12, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000454204.5
Allele description [Variation Report for NM_024675.4(PALB2):c.2368C>T (p.Gln790Ter)]
NM_024675.4(PALB2):c.2368C>T (p.Gln790Ter)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
delta-sarcoglycan isoform X1 [Seriola dumerili]
delta-sarcoglycan isoform X1 [Seriola dumerili]gi|1250152870|ref|XP_022616591.1|Protein
-
PREDICTED: Canis lupus familiaris phospholipase A2 group VI (PLA2G6), transcript...
PREDICTED: Canis lupus familiaris phospholipase A2 group VI (PLA2G6), transcript variant X1, mRNAgi|1952671935|ref|XM_856002.6|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024